OVARIAN CANCER STAGE III

This adverse event was reported 347 times

These drugs are most commonly taken by patients reporting OVARIAN CANCER STAGE III:

# Drug Count
0 ETANERCEPT 16
1 NIRAPARIB 14
2 CARBOPLATIN 13
3 INTERFERON BETA-1A 13
4 METHOTREXATE SODIUM 13
5 RANITIDINE 13
6 METHOTREXATE 12
7 PANTOPRAZOLE 10
8 ADALIMUMAB 9
9 NATALIZUMAB 8
See all common drugs associated with OVARIAN CANCER STAGE III

OVARIAN CANCER STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SALICYCLIC ACID 1 0.1000
1 MIRVETUXIMAB SORAVTANSINE 3 0.0017
2 AMILORIDE HYDROCHLORIDE 1 0.0012
3 PHENELZINE SULFATE 1 0.0006
4 NIRAPARIB 14 0.0006
5 AMINOPHYLLINE 1 0.0005
6 SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE 2 0.0005
7 HYPROMELLOSE 1 0.0004
8 LEVONORGESTREL AND ETHINYL ESTRADIOL 1 0.0004
9 BARICITINIB 1 0.0003
See all drugs enriched for association with OVARIAN CANCER STAGE III